Awakn Life Sciences reports its Q3 for fiscal 2021. Highlights include key IP and clinic acquisitions, and the company's first revenues.
MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD
MindMed's Phase IIa clinical trial of LSD for adults ADHD is officially underway, enrolling patients.
MINDCURE Nears Finish Line With iSTRYM Commercialization
MINDCURE moves an important step closer to the full commercial deployment of its iSTRYM digital therapeutics platform, and also makes a key addition to its management team.
Gold price hits daily highs
Gold pared its losses and rose to new daily highs as Federal Reserve Chair Jerome Powell explains 'real-time' policy making, inflation and maximum employment.
Gold, silver see solid price gains, post FOMC
Gold and silver prices are posting good gains in early U.S. trading.
MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second Quarter of 2022
HIPAA compliance certification is the next step for the Company in working towards having the iSTRYM technology platform classified a ‘Software as a Medical Device’ by the FDA.
Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety Disorders
Cybin Inc receives its Notice of Allowance from the USPTO with respect to its patent for CYB004.
MindMed Appoints Robert Barrow as Chief Executive Officer and Director
MindMed announces that interim CEO Robert Barrow has now been named the permanent CEO, and added as a Director.
atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated with Schizophrenia
atai partner, Recognify Life Sciences, reports positive Phase 2a results in treating Cognitive Impairment Associated with Schizophrenia.
MINDCURE (CSE: MCUR) (OTCQX: MCURF) Appoints Dr. Doron Sagman as Chief Medical Officer
Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) announces the appointment of Doron Sagman, MD, FRCPC, as the Company’s new Chief Medical Officer (“CMO”)
The Military Mental Health Crisis, A National Tragedy: Part I
The ongoing and worsening mental health crisis in the U.S. military is a national tragedy and a national disgrace. Part I reveals the ugly Big Picture.
Mild price gains in gold, silver ahead of big central bank week
It's a huge week for central banks meetings that will grab the spotlight. February gold was last up $5.50 at $1,790.40 and March Comex silver was last up $0.105 at $23.30 an ounce.
